← Back
$CGON All transactions

CG Oncology, Inc.

▼ SELL 10b5-1 Plan

$ Value

$200K

Shares

5,000

Price

$40

Filed

Oct 1

Insider

Name

POST LEONARD E

Title

CIK

0001235862

Roles

Director

Transaction Details

Transaction Date

2025-09-30

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. | Fully vested

Filing Info

Accession No.

0001193125-25-226964

Form Type

4

Issuer CIK

0001991792

POST LEONARD E's History

Date Ticker Type Value
2025-11-17 CGON M $600
2025-11-17 CGON $41K
2025-11-17 CGON M $0
2025-10-13 CGON M $600
2025-10-13 CGON $43K
2025-10-13 CGON M $0
2025-09-30 CGON M $3K
2025-09-30 CGON $200K
2025-09-30 CGON M $0
2025-09-15 CGON M $600

Other Insiders at CGON (90d)

Insider Bought Sold Last
DETORE JAMES M.
Chief Financial Officer
2026-04-15
Mulay James $1.1M 2026-04-17
Patterson Joshua F.
See Remarks
2026-04-15
Bellete Ambaw
President and COO
2026-04-15
Kuan Arthur
Chief Executive Officer
2026-04-15
Kasturi Vijay
Chief Medical Officer
2026-04-15